Literature DB >> 23897095

Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome.

J C Deddens1, J M Colijn, M I F J Oerlemans, G Pasterkamp, S A Chamuleau, P A Doevendans, J P G Sluijter.   

Abstract

Small non-coding microRNAs (miRNAs) are important physiological regulators of post-transcriptional gene expression. miRNAs not only reside in the cytoplasm but are also stably present in several extracellular compartments, including the circulation. For that reason, miRNAs are proposed as diagnostic biomarkers for various diseases. Early diagnosis of acute coronary syndrome (ACS), especially non-ST elevated myocardial infarction and unstable angina pectoris, is essential for optimal treatment outcome, and due to the ongoing need for additional identifiers, miRNAs are of special interest as biomarkers for ACS. This review highlights the nature and cellular release mechanisms of circulating miRNAs and therefore their potential role in the diagnosis of myocardial infarction. We will give an update of clinical studies addressing the role of circulating miRNA expression after myocardial infarction and explore the diagnostic value of this potential biomarker.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23897095     DOI: 10.1007/s12265-013-9493-9

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  134 in total

Review 1.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

Review 2.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

3.  MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction.

Authors:  Emanuela Bostjancic; Nina Zidar; Dusan Stajer; Damjan Glavac
Journal:  Cardiology       Date:  2009-12-21       Impact factor: 1.869

4.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

5.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

6.  Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction.

Authors:  G S Bodor; S Porter; Y Landt; J H Ladenson
Journal:  Clin Chem       Date:  1992-11       Impact factor: 8.327

7.  MicroRNA miR-1 is up-regulated in remote myocardium in patients with myocardial infarction.

Authors:  E Bostjancic; N Zidar; D Stajner; D Glavac
Journal:  Folia Biol (Praha)       Date:  2010       Impact factor: 0.906

8.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

9.  Exosomes: secreted vesicles and intercellular communications.

Authors:  Clotilde Théry
Journal:  F1000 Biol Rep       Date:  2011-07-01

10.  MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1.

Authors:  Jia Liu; Alain van Mil; Krijn Vrijsen; Jiajun Zhao; Ling Gao; Corina H G Metz; Marie-José Goumans; Pieter A Doevendans; Joost P G Sluijter
Journal:  J Cell Mol Med       Date:  2010-06-09       Impact factor: 5.310

View more
  20 in total

Review 1.  Advances in induced pluripotent stem cells, genomics, biomarkers, and antiplatelet therapy highlights of the year in JCTR 2013.

Authors:  Emanuele Barbato; Enrique Lara-Pezzi; Craig Stolen; Angela Taylor; Paul J Barton; Jozef Bartunek; Paul Iaizzo; Daniel P Judge; Lorrie Kirshenbaum; Burns C Blaxall; Andre Terzic; Jennifer L Hall
Journal:  J Cardiovasc Transl Res       Date:  2014-07       Impact factor: 4.132

2.  An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells: Role of MicroRNA-223 in Smooth Muscle Function and Atherogenesis.

Authors:  Zhen Shan; Shanshan Qin; Wen Li; Weibin Wu; Jian Yang; Maoping Chu; Xiaokun Li; Yuqing Huo; Gary L Schaer; Shenming Wang; Chunxiang Zhang
Journal:  J Am Coll Cardiol       Date:  2015-06-16       Impact factor: 24.094

Review 3.  MicroRNAs as biomarkers for clinical studies.

Authors:  Igor P Pogribny
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-15

Review 4.  In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.

Authors:  Casper F T van der Ven; Pin-Jou Wu; Mark W Tibbitt; Alain van Mil; Joost P G Sluijter; Robert Langer; Elena Aikawa
Journal:  Clin Sci (Lond)       Date:  2017-02-01       Impact factor: 6.124

Review 5.  Systems Biology and Noninvasive Imaging of Atherosclerosis.

Authors:  Claudia Calcagno; Willem J M Mulder; Matthias Nahrendorf; Zahi A Fayad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02       Impact factor: 8.311

Review 6.  Linking Genes to Cardiovascular Diseases: Gene Action and Gene-Environment Interactions.

Authors:  Ares Pasipoularides
Journal:  J Cardiovasc Transl Res       Date:  2015-11-06       Impact factor: 4.132

7.  The plasma proteomic signature as a strategic tool for early diagnosis of acute coronary syndrome.

Authors:  Carlos M Laborde; Sergio Alonso-Orgaz; Laura Mourino-Alvarez; José Moreu; Fernando Vivanco; Luis R Padial; María G Barderas
Journal:  Proteome Sci       Date:  2014-10-10       Impact factor: 2.480

8.  MiR-181a: a potential biomarker of acute muscle wasting following elective high-risk cardiothoracic surgery.

Authors:  Susannah A A Bloch; Anna V J Donaldson; Amy Lewis; Winston A S Banya; Michael I Polkey; Mark J D Griffiths; Paul R Kemp
Journal:  Crit Care       Date:  2015-04-07       Impact factor: 9.097

9.  MicroRNA Stability in Postmortem FFPE Tissues: Quantitative Analysis Using Autoptic Samples from Acute Myocardial Infarction Patients.

Authors:  Yu Kakimoto; Hiroshi Kamiguchi; Eriko Ochiai; Fumiko Satoh; Motoki Osawa
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

Review 10.  Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells.

Authors:  Mei-Hua Bao; Xing Feng; Yi-Wen Zhang; Xiao-Ya Lou; Yu Cheng; Hong-Hao Zhou
Journal:  Int J Mol Sci       Date:  2013-11-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.